ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways

Guo, Qinhua; Guo, Pin; Mao, Qing; Lan, Jin; Lin, Yingying; Jiang, Jiyao; Qiu, Yongming
March 2013
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
Academic Journal
Glioblastoma multiforme (GBM) is characterized by poor therapeutic response and poor overall survival. It is crucial that more effective therapies be developed for the treatment of GBM. Inhibitor of DNA binding protein-1 (ID1) has been shown to maintain the self-renewal capacity of neural stem cells and might be involved in the therapeutic resistance of GBM. In the present study, we explored survival data from the The Cancer Genome Atalas database that were based on ID1 expression for patients diagnosed with primary GBMs. Interestingly, patients with high ID1 expression had better survival than patients with low ID1 expression, and a strong correlation was found between radiotherapy efficacy, ID1 expression, and overall survival. We further investigated the relationship between ID1 expression and the radiosensitivity of glioblastoma using glioblastoma cell lines. The clonogenic formation assay showed that U87 ID1-shRNA cells were much less sensitive to radiation. Moreover, both the results of the γH2AX foci staining assay and the comet assay further revealed that ID1 negatively regulates DNA repair processes by downregulating the expression of genes such as DNA ligase IV (LIG4) and ataxia-telangiectasia-mutated. Additionally, ID1 induces G2/M arrest in U87 cells. Taken together, these results suggest that ID1 may be a new prognostic marker for GBM and have important implications for the therapeutic strategies used to treat GBM patients.


Related Articles

  • Association between RAD 51 rs1801320 and susceptibility to glioblastoma. Franceschi, S.; Tomei, S.; Mazzanti, C.; Lessi, F.; Aretini, P.; La Ferla, M.; De Gregorio, V.; Pasqualetti, F.; Zavaglia, K.; Bevilacqua, G.; Naccarato, A. // Journal of Neuro-Oncology;Jan2016, Vol. 126 Issue 2, p265 

    Glioblastoma is the most common and aggressive malignant primary brain tumor. Despite decades of research and the advent of new therapies, patients with glioblastoma continue to have a very poor prognosis. Radiation therapy has a major role as adjuvant treatment for glioblastoma following...

  • Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer. Cron, Kyle R.; Zhu, Kaya; Kushwaha, Deepa S.; Hsieh, Grace; Merzon, Dmitry; Rameseder, Jonathan; Chen, Clark C.; D’Andrea, Alan D.; Kozono, David // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most...

  • Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells. Cong, Zi-Xiang; wang, Han-Dong; Zhou, Yuan; Wang, Jia-Wei; Pan, Hao; Zhang, Ding-Ding; Zhang, Li; Zhu, Lin // Journal of Neuro-Oncology;Jan2014, Vol. 116 Issue 1, p41 

    Resistance to chemoradiotherapy is a major obstacle to successful treatment of glioblastoma. Recently, the role of NF-E2-related factor 2 (Nrf2) in enhancing chemoradiation sensitivity has been reported in several types of cancers. Here, we investigated whether temozolomide (TMZ) and irradiation...

  • Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Kesanakurti, D; Chetty, C; Rajasekhar Maddirela, D; Gujrati, M; Rao, J S // Oncogene;10/24/2013, Vol. 32 Issue 43, p5144 

    Although radiotherapy improves survival in patients, glioblastoma multiformes (GBMs) tend to relapse with augmented tumor migration and invasion even after ionizing radiation (IR). Aberrant nuclear factor-κB (NF-κB) and signal transducer and activator of transcription factor 3 (Stat3)...

  • Blockade of the NF?B pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo. Nogueira, L; Ruiz-Onta�on, P; Vazquez-Barquero, A; Lafarga, M; Berciano, M T; Aldaz, B; Grande, L; Casafont, I; Segura, V; Robles, E F; Suarez, D; Garcia, L F; Martinez-Climent, J A; Fernandez-Luna, J L // Oncogene;8/11/2011, Vol. 30 Issue 32, p3537 

    Glioblastoma multiforme is one of the most devastating cancers and presents unique challenges to therapy because of its aggressive behavior. Cancer-initiating or progenitor cells have been described to be the only cell population with tumorigenic capacity in glioblastoma. Therefore, effective...

  • Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line? Lawrence, Yaacov; Blumenthal, Deborah; Matceyevsky, Diana; Kanner, Andrew; Bokstein, Felix; Corn, Benjamin // Journal of Neuro-Oncology;Oct2011, Vol. 105 Issue 1, p1 

    Glioblastoma is a malignant tumor characterized by a rapid proliferation rate. Contemporary multi-modality treatment consists of maximal surgical resection followed by radiation therapy (RT) combined with cytotoxic chemotherapy. The optimal timing of these different steps is not known. Four...

  • Rethinking immunotherapy for brain cancers in the light of cancer complexity. Grizzi, Fabio; Di Ieva, Antonio // Indian Journal of Medical Research;May2013, Vol. 137 Issue 5, p871 

    The article discusses the search for new and more targeted therapeutic options for brain cancers despite available treatments including surgical resection, radiation therapy and cytotoxic chemotherapy. The authors attribute the situation to the incurability of brain cancers. They cite the...

  • Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [18F]FLT-PET Imaging. Viel, Thomas; Schelhaas, Sonja; Wagner, Stefan; Wachsmuth, Lydia; Schwegmann, Katrin; Kuhlmann, Michael; Faber, Cornelius; Kopka, Klaus; Schäfers, Michael; Jacobs, Andreas H. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    : Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early during treatment would be...

  • Decreased CUL4B expression inhibits malignant proliferation of glioma in vitro and in vivo. DONG, J.; WANG, X. -Q.; YAO, J. -J.; LI, G.; LI, X. -G. // European Review for Medical & Pharmacological Sciences;Mar2015, Vol. 19 Issue 6, p1013 

    OBJECTIVE: Cullin 4B (CUL4B) is a component of the Cullin 4B-Ring E3 ligase complex (CRL4B) that plays a role in proteolysis and is implicated in tumorigenesis. However, little is known about CUL4B function in human brain tumors, including glioma. MATERIALS AND METHODS: Here, to investigate the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics